This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
Top Analyst Reports for Broadcom, Canadian National & CVS Health
by Zacks Equity Research
Today's Research Daily features new research reports on 16 major stocks, including Broadcom (AVGO), Canadian National (CNI) and CVS Health (CVS).
CVS Health (CVS) Beats On Q4 Earnings & Revenues Estimates
by Zacks Equity Research
CVS Health (CVS) rides high on strength in Pharmacy Services segment in Q4.
Health Insurance Stock Outlook - January 2018
by Zacks Equity Research
Rapid evolution is being witnessed in the health insurance industry as the players are taking concerted efforts to transform themselves into comprehensive health care providers from their earlier role of traditional payers.
Fred's (FRED) Sluggish Store Sales Keep Investors at Bay
by Zacks Equity Research
Fred's (FRED) continues to witness dismal comps and store closures. Also, cancelled dividend and merger deal make this retailer a less-favored pick.
5 Reasons Why McKesson Deserves a Place in Your Portfolio
by Zacks Equity Research
McKesson (MCK) continues to pursue deals, divestitures and acquisitions to drive growth. The company's impressive performance in 2017 accounts for its potential to sustain the momentum.
Company News For January 5, 2018
by Zacks Equity Research
Companies In The News are:
CVS Health's (CVS) Outlook for 2018 Cheered by Investors
by Zacks Equity Research
CVS Health (CVS) to witness increased cash flow of around $1.2 billion in 2018, courtesy the latest US Tax legislation.
Fred's Tanks 79% in a Year: Any Chances of Revival Ahead?
by Zacks Equity Research
Fred's (FRED) has been struggling with its dismal comps performance stemming from receding traffic and store closures. Also, management cancelled its quarterly dividend recently.
Declining Comps Likely to Hurt Fred's (FRED) in Q3 Earnings
by Zacks Equity Research
Fred's (FRED) third-quarter fiscal 2017 performance is expected to be hurt by dismal comps trend.
Company News For Nov 7, 2017
by Zacks Equity Research
Companies In The News are: ON,BRK.B,S,TMUS,CVS
McKesson (MCK) to Acquire RxCrossroads for $735 Million
by Zacks Equity Research
McKesson's (MCK) acquisition of RxCrossroads will boost its Specialty Health business.
CVS Health (CVS) Beats On Q3 Earnings, Revenues In Line
by Zacks Equity Research
CVS Health (CVS) witnesses year over year growth in Pharmacy Services segment in Q3.
Is a CVS Health (CVS) - Aetna (AET) Deal in the Cards?
by Arpita Dutt
Is an e-commerce company's interest in entering the drug pharmacy space the reason behind CVS Health's (CVS) interest in acquiring Aetna?
Rite Aid (RAD) Slumps 14% Since Q2 Loss: What Lies Ahead?
by Zacks Equity Research
Rite Aid Corporation (RAD), which had quite an eventful journey of late, reported dismal second-quarter fiscal 2018 results last week. However, latest deal with Walgreens should benefit.
Can Fred's Strategies Help It Counter Slow Comps & Traffic?
by Zacks Equity Research
Fred's (FRED) has been struggling with declining store traffic and sluggish comps over the past few quarters. The company has been focusing on cost reduction and internal restructuring.
What FTC's Curtail on RAD Store Purchase Means for Walgreens?
by Zacks Equity Research
Walgreens' (WBA) purchase of lesser number of Rite Aid stores upsets investors. Let's draw an insight from this.
Rite Aid Gets FTC Nod for Sale of Fewer Stores to Walgreens
by Zacks Equity Research
After four amendments, Rite Aid Corp. (RAD) and Walgreens Boots Alliance Inc. (WBA) finally received a nod for the fresh proposal the latter put forward yesterday.
Why Did Rite Aid (RAD) Stock Crash Today?
by Ryan McQueeney
Shares of Rite Aid (RAD) fell more than 10% on Tuesday after Walgreens Boots (WBA) received government approval to buy fewer Rite Aid stores than had initially been proposed.
Walgreens to Revisit Rite Aid Deal for Antitrust Approval
by Zacks Equity Research
The Federal Trade Commission ("FTC") seems to be getting harsher on drugstore chains Walgreens Boots Alliance Inc. (WBA) and Rite Aid Corp. (RAD), which have been trying to appease the regulatory body since its initial merger pact in 2015.
The Zacks Analyst Blog Highlights: Disney, Kraft Heinz and CVS Health, Intercontinental Exchange and Ventas
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Disney, Kraft Heinz and CVS Health, Intercontinental Exchange and Ventas
Tobacco Stocks in Focus as Cigarette Prices Rise in New York
by Zacks Equity Research
The news of cigarette price hike in New York City and other legislations to reduce the number of smokers have raised concerns of accelerated sales declines for traditional cigarettes.
What You Should Know About Fred's Apart From Dismal Comps
by Zacks Equity Research
Fred's (FRED) is yet to recover from the cancelled Walgreens-Rite Aid merger. The company has also been struggling with declining sales owing to lower comps and store closures.
Investors Are Keeping An Eye On Q2 Earnings
by Zacks Equity Research
Investors Are Keeping An Eye On Q2 Earnings
Q2 Earnings Rundown: KORS, RL, CVS & More
by Mark Vickery
The S&P 500 and Dow both hit new record highs yesterday, but are down marginally in today's pre-market.
CVS Health Beats on Q2 Earnings and Revenue Estimates
by Zacks Equity Research
CVS Health(CVS) rides high on Pharmacy Services segment in Q2.